Editorial: Probing the Chromatin Architecture by Palombo, Francesca et al.








Editorial: Probing the Chromatin Architecture
Palombo, Francesca ; Pagliara, Stefano ; Singh, Ankur ; Chahwan, Richard
DOI: https://doi.org/10.3389/fcell.2021.727803






The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Palombo, Francesca; Pagliara, Stefano; Singh, Ankur; Chahwan, Richard (2021). Editorial: Probing the
Chromatin Architecture. Frontiers in Cell and Developmental Biology, 9:727803.
DOI: https://doi.org/10.3389/fcell.2021.727803
EDITORIAL
published: 29 July 2021
doi: 10.3389/fcell.2021.727803
Frontiers in Cell and Developmental Biology | www.frontiersin.org 1 July 2021 | Volume 9 | Article 727803
Edited and reviewed by:
Cecilia Giulivi,






This article was submitted to
Cellular Biochemistry,
a section of the journal
Frontiers in Cell and Developmental
Biology
Received: 27 June 2021
Accepted: 07 July 2021
Published: 29 July 2021
Citation:
Palombo F, Pagliara S, Singh A and
Chahwan R (2021) Editorial: Probing
the Chromatin Architecture.
Front. Cell Dev. Biol. 9:727803.
doi: 10.3389/fcell.2021.727803
Editorial: Probing the Chromatin
Architecture
Francesca Palombo 1*, Stefano Pagliara 2, Ankur Singh 3,4 and Richard Chahwan 5
1 School of Physics and Astronomy, University of Exeter, Exeter, United Kingdom, 2 Living Systems Institute and School of
Biosciences, University of Exeter, Exeter, United Kingdom, 3Woodruff School of Mechanical Engineering, Georgia Institute of
Technology, Atlanta, GA, United States, 4Coulter Department of Biomedical Engineering, Georgia Institute of Technology and
Emory University School of Medicine, Atlanta, GA, United States, 5 Institute of Experimental Immunology, University of Zurich,
Zurich, Switzerland
Keywords: chromatin organization, cell phenotyping, genome, cancer therapy, vibrational spectroscopy, imaging,
confocal microscopy
Editorial on the Research Topic
Probing the Chromatin Architecture
Chromatin architecture plays an essential role in gene regulation, cell differentiation, response to
external cues, and disease progression, and hence can be used as a biomarker for cell phenotyping.
Traditionally, methods based on confocal microscopy and imaging using fluorescent tags have
been employed to study the chromatin architecture inside the nucleus by measuring the location
and folding of chromosomes. However, existing methods lack specificity and/or are reliant on
extrinsic labeling that prevents yielding structural information for chromatin in its native state
by potentially interfering with ongoing biological processes. In this Research Topic, we focus on
technical advancements in (i) measuring chromatin changes at the single-cell level, (ii) studying
chromatin modification through DNA methylation, and (iii) visualizing chromatin by super-
resolution microscopy. We also review the literature on (i) protein post-translational modifications
and their impact on the scaffold/matrix interactions of the chromatin, (ii) advancements in using
epigenomic biosensors during radiotherapy, and (iii) the effect of small molecule inhibitors on
chromatin-associated cellular responses.
Morrish et al. describe a label-free imaging approach based on two complementary chromatin
probing methods—Raman microscopy in microfluidic devices and transcriptomic analysis—that
enables direct linking of Raman spectral signatures of the nucleus of lymphocyte cells with
>17,000 distinct transcripts upon immune activation of B lymphocytes. This approach, built on
a previous method based on Raman spectroscopy, was applied to image >100 activated and non-
activated live B cells at high resolution in a specially designed microfluidic chip. This complex
set of cellular Raman maps was analyzed via a multivariate common k-means cluster analysis
approach. This analysis permitted identifying distinct spectral profiles associated with the nucleus
and cytoplasm. Next, principal component analysis (PCA) and linear discriminant analysis (LDA)
allowed elucidating the discriminants between activated and non-activated cells. This label-free
imaging classification has exciting potential in biology. For instance, it can be used in cell sorting
based on chemical phenotyping of the nucleus, or in clinical translation for label-free disease
diagnosis and prognosis. Finally, the team quantified linear correlations between nuclear Raman
spectra and transcriptomic data, generating a partial least squares (PLS) regressionmatrix to predict
Raman data from transcriptomic profiles. This approach was used to identify the key transcripts
and thereby reveal genes or pathways that are essential for the immune activation process, including
the immunoglobulin genes Ighm and Igha, regulatory RNAs and proteins.
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An alternative approach for tracing chromatin dynamic
changes used genome-wide quantification of DNA methylation
in induced pluripotent stem cells (iPSCs) during differentiation
and maturation into cortical neurons. This method, based on
data-driven trajectory inference, allows identification of DNA
methylomic trajectories of neuronal differentiation. Up to 6,843
Bonferroni-significant loci (out of the 41,851 loci measured)
were identified based on the presence of progressive alterations
in DNA methylation during differentiation into neurons and
subsequent maturation. By applying a gene-gene interaction
network analysis, the authors were able to identify 60 densely
connected genes that were influential in neuronal differentiation
from iPSCs, particularly those encoding transcription factors and
epigenetic regulators (Imm et al.).
A complementary approach for visualizing chromatin
architecture and its epigenomic states with nanometric
resolution in cells and tissue used super-resolution imaging
based on single molecule localization microscopy (SMLM),
as reported in this review (Xu and Liu). SMLM-based super-
resolution imaging of nanoscale chromatin architecture and its
dynamic behaviors was applied to study healthy and pathological
processes in developmental biology, immunology, and oncology.
The authors propose that in the future the SMLM imaging
approach for tracing chromatin architecture could improve
cancer diagnosis, enabling the development and evaluation of
new early detection strategies.
Chromatin architecture is based on the interaction between
DNA and histones as well as the post-translational modifications
(PTMs) of non-histone-associated proteins. Among the
main proteins responsible for maintaining the 3D genomic
architecture, S/MAR-binding proteins (S/MARBPs) play a
key role in binding to the scaffold/matrix attachment regions
(S/MARs) and mediating tethering of the chromatin to
the protein matrix. A review of the current understanding,
scope, disease implications, and future perspectives of the
diverse post-translational modifications that regulate the
functions of S/MARBPs is featured here (Roychowdhury
and Chattopadhyay).
Finally, approaches relying on a combination of drugs
affecting the epigenomic landscape and radiotherapy along
with chromatin epigenetic monitoring based on fluorescence
resonance energy transfer (FRET) biosensors may lead to
improvement in cancer treatment. However, although beneficial,
such approaches have been evaluated in several ongoing
clinical trials for limited cancer types, partly due to a lack of
knowledge on the mechanisms on radiation-induced epigenomic
regulation and chromatin remodeling. Peng et al. review recent
advances in radiotherapy and epigenomic remodeling and
propose that, in the future, a FRET-based approach could be
used for epigenetic monitoring and chromatin architecture
probing in tumor cells upon exposure to radiation, and for
screening drugs that influence the epigenomic landscape
which, when combined with radiotherapy, can improve
cancer treatment.
One example of such epigenetic drugs, valproic acid (VPA),
was originally prescribed for the treatment of seizure disorders
and is now known to affect epigenetic markers and chromatin
structure, as reviewed here (Mello). VPA indirectly promotes
histone acetylation by inhibiting the deacetylation process, and
therefore it can induce chromatin decondensation, as revealed
through imaging techniques such as Fourier Transform Infrared
(FTIR) spectroscopic imaging. This finding suggests that VPA
could affect the methylation status of histones, and possibly
DNA, and hence could have therapeutic potential due to its
antitumour effects.
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